STVN

Vaccine vial maker Stevanato raises $672 million in U.S. IPO

Stevanato said in a statement it priced 32 million shares at $21 per share, compared to its previous plan of 40 million shares at indicated price range of $21 to $24. The IPO values Stevanato at $6.3 billion.